fda not allowing compounded semaglutide The FDA has removed semaglutide injection products (GLP-1) from the FDA ends semaglutide shortage, closing
Description
Saxenda, a once-daily injectable, may also cost less

[DOI] [PubMed] [Google Scholar] 196.Wiggins T., Guidozzi N., Welbourn R., Ahmed A.R., Markar S.R

B.ElbrondB.RolanP.ZdravkovicM
If the same vial were diluted with 4mL of water, the concentration would be halved to 2,500mcg/mL, and the same 2,500mcg dose would now require 1mL, or 100 units

It also plays a role in tissue repair and metabolic regulation